| Year |
Citation |
Score |
| 2023 |
Magen I, Yacovzada NS, Warren JD, Heller C, Swift I, Bobeva Y, Malaspina A, Rohrer JD, Fratta P, Hornstein E. microRNA-based predictor for diagnosis of frontotemporal dementia. Neuropathology and Applied Neurobiology. e12916. PMID 37317649 DOI: 10.1111/nan.12916 |
0.487 |
|
| 2022 |
Magen I, Aharoni S, Yacovzada NS, Tokatly Latzer I, Alves CRR, Sagi L, Fattal-Valevski A, Swoboda KJ, Katz J, Bruckheimer E, Nevo Y, Hornstein E. Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients. European Journal of Neurology. PMID 35510740 DOI: 10.1111/ene.15382 |
0.532 |
|
| 2021 |
Magen I, Yacovzada NS, Yanowski E, Coenen-Stass A, Grosskreutz J, Lu CH, Greensmith L, Malaspina A, Fratta P, Hornstein E. Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis. Nature Neuroscience. 24: 1534-1541. PMID 34711961 DOI: 10.1038/s41593-021-00936-z |
0.599 |
|
| 2019 |
Reichenstein I, Eitan C, Diaz-Garcia S, Haim G, Magen I, Siany A, Hoye ML, Rivkin N, Olender T, Toth B, Ravid R, Mandelbaum AD, Yanowski E, Liang J, Rymer JK, et al. Human genetics and neuropathology suggest a link between miR-218 and amyotrophic lateral sclerosis pathophysiology. Science Translational Medicine. 11. PMID 31852800 DOI: 10.1126/Scitranslmed.Aav5264 |
0.558 |
|
| 2018 |
Coenen-Stass AML, Magen I, Brooks T, Ben-Dov IZ, Greensmith L, Hornstein E, Fratta P. Evaluation of methodologies for microRNA biomarker detection by next generation sequencing. Rna Biology. 1-13. PMID 30223713 DOI: 10.1080/15476286.2018.1514236 |
0.559 |
|
| 2017 |
Rotem N, Magen I, Ionescu A, Gershoni-Emek N, Altman T, Costa CJ, Gradus T, Pasmanik-Chor M, Willis DE, Ben-Dov IZ, Hornstein E, Perlson E. ALS Along the Axons - Expression of Coding and Noncoding RNA Differs in Axons of ALS models. Scientific Reports. 7: 44500. PMID 28300211 DOI: 10.1038/Srep44500 |
0.567 |
|
| 2015 |
Emde A, Eitan C, Liou LL, Libby RT, Rivkin N, Magen I, Reichenstein I, Oppenheim H, Eilam R, Silvestroni A, Alajajian B, Ben-Dov IZ, Aebischer J, Savidor A, Levin Y, et al. Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: a new mechanism for ALS. The Embo Journal. 34: 2633-51. PMID 26330466 DOI: 10.15252/Embj.201490493 |
0.579 |
|
| 2014 |
Magen I, Hornstein E. Oligonucleotide-based therapy for neurodegenerative diseases. Brain Research. 1584: 116-28. PMID 24727531 DOI: 10.1016/J.Brainres.2014.04.005 |
0.51 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2020 |
Asulin N, Volinsky N, Grosman-Rimon L, Kachel E, Sternik L, Raanani E, Altshuler R, Magen I, Ben-Zvi I, Margalit N, Carasso S, Meir K, Haviv I, Amir O. Differential microRNAs expression in calcified versus rheumatic aortic valve disease. Journal of Cardiac Surgery. PMID 32485041 DOI: 10.1111/jocs.14636 |
0.281 |
|
| 2017 |
Richter F, Subramaniam SR, Magen I, Lee P, Hayes J, Attar A, Zhu C, Franich NR, Bove N, De La Rosa K, Kwong J, Klärner FG, Schrader T, Chesselet MF, Bitan G. A Molecular Tweezer Ameliorates Motor Deficits in Mice Overexpressing α-Synuclein. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 28585223 DOI: 10.1007/S13311-017-0544-9 |
0.156 |
|
| 2013 |
Magen I, Gozes I. Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: focus on davunetide (NAP). Neuropeptides. 47: 489-95. PMID 24210139 DOI: 10.1016/j.npep.2013.10.011 |
0.129 |
|
| 2012 |
Chesselet MF, Richter F, Zhu C, Magen I, Watson MB, Subramaniam SR. A progressive mouse model of Parkinson's disease: the Thy1-aSyn ("Line 61") mice. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 9: 297-314. PMID 22350713 DOI: 10.1007/S13311-012-0104-2 |
0.124 |
|
| 2022 |
Avraham Y, Van Heukelom B, Zolotarev O, Magen I, Vorobiev L, Zwas DR. Insulin normalized brain metabolic status on a Model of Anorexia Nervosa in Mice. Physiology & Behavior. 249: 113738. PMID 35182554 DOI: 10.1016/j.physbeh.2022.113738 |
0.12 |
|
| 2010 |
Avraham Y, Davidi N, Porat M, Chernoguz D, Magen I, Vorobeiv L, Berry EM, Leker RR. Leptin reduces infarct size in association with enhanced expression of CB2, TRPV1, SIRT-1 and leptin receptor. Current Neurovascular Research. 7: 136-43. PMID 20374198 DOI: 10.2174/156720210791184943 |
0.12 |
|
| 2008 |
Avraham Y, Magen I, Zolotarev O, Vorobiav L, Nachmias A, Pappo O, Ilan Y, Berry EM, Ackerman Z. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist, in various rat tissues during the evolution of experimental cholestatic liver disease. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 79: 35-40. PMID 18771906 DOI: 10.1016/j.plefa.2008.07.003 |
0.12 |
|
| 2010 |
Magen I, Chesselet MF. Genetic mouse models of Parkinson's disease The state of the art. Progress in Brain Research. 184: 53-87. PMID 20887870 DOI: 10.1016/S0079-6123(10)84004-X |
0.119 |
|
| 2014 |
Magen I, Ostritsky R, Richter F, Zhu C, Fleming SM, Lemesre V, Stewart AJ, Morimoto BH, Gozes I, Chesselet MF. Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synuclein. Pharmacology Research & Perspectives. 2: e00065. PMID 25505609 DOI: 10.1002/Prp2.65 |
0.116 |
|
| 2011 |
Magen I, Chesselet MF. Mouse models of cognitive deficits due to alpha-synuclein pathology. Journal of Parkinson's Disease. 1: 217-27. PMID 23939303 DOI: 10.3233/Jpd-2011-11043 |
0.112 |
|
| 2009 |
Magen I, Avraham Y, Ackerman Z, Vorobiev L, Mechoulam R, Berry EM. Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation Journal of Hepatology. 51: 528-534. PMID 19596476 DOI: 10.1016/J.Jhep.2009.04.021 |
0.11 |
|
| 2015 |
Magen I, Torres ER, Dinh D, Chung A, Masliah E, Chesselet MF. Social Cognition Impairments in Mice Overexpressing Alpha-Synuclein Under the Thy1 Promoter, a Model of Pre-manifest Parkinson's Disease. Journal of Parkinson's Disease. PMID 25588356 DOI: 10.3233/Jpd-140503 |
0.106 |
|
| 2008 |
Magen I, Avraham Y, Berry E, Mechoulam R. Endocannabinoids in liver disease and hepatic encephalopathy Current Pharmaceutical Design. 14: 2362-2369. PMID 18781986 DOI: 10.2174/138161208785740063 |
0.103 |
|
| 2014 |
Magen I, Gozes I. Davunetide: Peptide therapeutic in neurological disorders. Current Medicinal Chemistry. 21: 2591-8. PMID 24533805 DOI: 10.2174/0929867321666140217124945 |
0.1 |
|
| 2018 |
Subramaniam SR, Magen I, Bove N, Zhu C, Lemesre V, Dutta G, Elias CJ, Lester HA, Chesselet MF. Chronic nicotine improves cognitive and social impairment in mice overexpressing wild type α-synuclein. Neurobiology of Disease. PMID 29859873 DOI: 10.1016/J.Nbd.2018.05.018 |
0.093 |
|
| 2011 |
Lam HA, Wu N, Cely I, Kelly RL, Hean S, Richter F, Magen I, Cepeda C, Ackerson LC, Walwyn W, Masliah E, Chesselet MF, Levine MS, Maidment NT. Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human α-synuclein. Journal of Neuroscience Research. 89: 1091-102. PMID 21488084 DOI: 10.1002/Jnr.22611 |
0.093 |
|
| 2012 |
Magen I, Fleming SM, Zhu C, Garcia EC, Cardiff KM, Dinh D, De La Rosa K, Sanchez M, Torres ER, Masliah E, Jentsch JD, Chesselet MF. Cognitive deficits in a mouse model of pre-manifest Parkinson's disease. The European Journal of Neuroscience. 35: 870-82. PMID 22356593 DOI: 10.1111/J.1460-9568.2012.08012.X |
0.081 |
|
| 2006 |
Avraham Y, Israeli E, Gabbay E, Okun A, Zolotarev O, Silberman I, Ganzburg V, Dagon Y, Magen I, Vorobia L, Pappo O, Mechoulam R, Ilan Y, Berry EM. Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice. Neurobiology of Disease. 21: 237-45. PMID 16102970 DOI: 10.1016/J.Nbd.2005.07.008 |
0.072 |
|
| 2022 |
Amitai M, Kaffman S, Kroizer E, Lebow M, Magen I, Benaroya-Milshtein N, Fennig S, Weizman A, Apter A, Chen A. Neutrophil to-lymphocyte and platelet-to-lymphocyte ratios as biomarkers for suicidal behavior in children and adolescents with depression or anxiety treated with selective serotonin reuptake inhibitors. Brain, Behavior, and Immunity. PMID 35470013 DOI: 10.1016/j.bbi.2022.04.018 |
0.07 |
|
| 2005 |
Dagon Y, Avraham Y, Magen I, Gertler A, Ben-Hur T, Berry EM. Nutritional status, cognition, and survival: a new role for leptin and AMP kinase. The Journal of Biological Chemistry. 280: 42142-8. PMID 16203737 DOI: 10.1074/jbc.M507607200 |
0.063 |
|
| 2011 |
Avraham Y, Saidian M, Burston JJ, Mevorach R, Vorobiev L, Magen I, Kunkes E, Borges B, Lichtman AH, Berry EM. Fish oil promotes survival and protects against cognitive decline in severely undernourished mice by normalizing satiety signals. The Journal of Nutritional Biochemistry. 22: 766-76. PMID 21109417 DOI: 10.1016/J.Jnutbio.2010.07.001 |
0.047 |
|
| 2008 |
Avraham Y, Zolotarev O, Grigoriadis NC, Poutahidis T, Pautahidis T, Magen I, Vorobiav L, Zimmer A, Ilan Y, Mechoulam R, Berry EM. Cannabinoids and capsaicin improve liver function following thioacetamide-induced acute injury in mice. The American Journal of Gastroenterology. 103: 3047-56. PMID 19086956 DOI: 10.1111/J.1572-0241.2008.02155.X |
0.045 |
|
| Hide low-probability matches. |